<DOC>
	<DOCNO>NCT01951183</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , placebo-controlled , parallel-group study evaluate efficacy , safety tolerability RO6811135 Type 2 diabetic patient treat stable dose metformin .</brief_summary>
	<brief_title>A Study RO6811135 Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Adults age 18 65 Have diagnose diabetes least 3 month treat stable dose metformin least 8 week Hemoglobin A1c 7.2 10.5 % Fasting plasma glucose le 250 mg/dL Cpeptide great 1.5 ng/mL Body mass index ( BMI ) 27 44 Pregnant lactate woman Type 1 diabetes Had undergone weight loss surgery weight loss procedure involve gastrointestinal tract , gastric bypass , gastric stapling , gastric banding Uncontrolled hypertension significant cardiovascular disease determine investigator Significant kidney liver disease determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>